Alnylam Pharmaceuticals · 9 hours ago
Sr. Manager, Accounts Payable - Automation & Process Improvement
Alnylam Pharmaceuticals is a leader in RNAi therapeutics, dedicated to transforming the lives of people with rare and common diseases. The Senior Manager, Accounts Payable will oversee the operational functions of the Accounts Payable Department, leveraging data analytics and automation to enhance efficiency and ensure exemplary customer service.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Lead and manage the Global Accounts Payable team, fostering a culture of excellence, collaboration, and continuous improvement
Build effective relationships and provide excellent stakeholder service across the company with various departments (Accounting, Operations, Commercial, Treasury, IT, HR, Audit, Marketing, Legal) and act as a business partner on Accounts Payable matters and inquiries
Develop and implement strategies to enhance the efficiency and scalability of payments function
Set direction for the Accounts Payable function to align with Finance team goals and support continuous improvement, analytics and automation across processes, systems, and team performance
Drive strategic initiatives within AP, including enhancing use of systems (SAP VIM, Ariba), and reducing manual or inefficient tasks
Identify and implement technology solutions and automation to streamline workflows and increase transparency in the AP process
Oversee the accuracy and timeliness of monthly close activities related to AP, including accruals, reconciliations, and vendor aging reviews
Oversee the day-to-day operations of processes, ensuring accuracy and timeliness in payment processing, financial reporting, transaction processing, and data reconciliation
Serve as the escalation point for complex vendor issues, payment discrepancies, or policy exceptions, working cross-functionally to resolve root causes
Maintain and enforce internal controls within AP, ensuring proper segregation of duties, approval workflows, and compliance with company policies
Support audit and compliance efforts (e.g. 1099's) by ensuring the AP function is well-organized, documented, and responsive to inquiries
Ensure compliance with all relevant accounting standards, regulations, and internal policies, mitigating risks and safeguarding the company’s financial integrity
Qualification
Required
7+ years of work experience with 5+ years in leading a Global Accounts Payable team
Prior operational experience using data analytics and automation within the Procure to Pay cycle is a must
Proven ability to interact with multiple levels of stakeholders both internally and externally
Self-directed, dynamic, and customer-centric change-agent who thrives in a challenging and changing environment
Highly collaborative; aligns effectively with colleagues and business partners to deliver results while maximizing the success of all contributors
Skilled communicator and proven relationship builder, able to operate within a multitude of formal and informal networks while managing the competing interests of varied stakeholders
Champions productivity improvements through Process Improvement and has a commitment to continuous learning
Bachelor's Degree Required
Excellent attention to detail required
Business acumen to develop effective partnerships with key stakeholders and provide a strategic perspective in discussions and communications
Preferred
Experience of SAP Ariba, VIM would be a plus
Benefits
Comprehensive benefits including medical, dental, and vision coverage
Life and disability insurance
A lifestyle reimbursement program
Flexible spending and health savings accounts
401(k) with a generous company match
Paid time off
Wellness days
Holidays
Two company-wide recharge breaks
Generous family resources and leave
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Recent News
2025-12-22
2025-12-20
Company data provided by crunchbase